Fc variants with altered binding to FcRn

Details for Australian Patent Application No. 2005304624 (hide)

Owner Xencor, Inc

Inventors Yoder, Sean Christopher; Karki, Sher Bahadur; Vielmetter, Jost; Chamberlain, Aaron Keith; Lazar, Greogory Alan; Desjarlais, John R.

Agent Davies Collison Cave

Pub. Number AU-B-2005304624

PCT Pub. Number WO2006/053301

Priority 60/703,018 27.07.05 US; 60/649,508 02.02.05 US; 60/681,607 16.05.05 US; 60/669,311 06.04.05 US; 60/642,886 11.01.05 US; 60/662,468 15.03.05 US; 60/690,200 13.06.05 US; 60/696,609 05.07.05 US; 60/726,453 12.10.05 US; 60/627,763 12.11.04 US

Filing date 14 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 7 October 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/053301 Priority application(s): WO2006/053301

7 October 2010 Application Accepted

  Published as AU-B-2005304624

3 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304630-Method of manufacture and bottling for encoded microclustered liquids

2005304622-Site-directed modification of FVIII